Table 3

The prevalence rate of population with T2DM risk factor according to quartiles of adiponectin

T2DM risk factorAdiponectinχ2P valueP value*
Quartile 1Quartile 2Quartile 3Quartile 4
High BMI level
 No281 (30.25)434 (47.54)553 (61.10)655 (73.60)379.29<0.001<0.001
 Yes648 (69.75)479 (52.26)352 (38.90)235 (26.40)
High WC level
 No277 (31.33)393 (45.07)513 (58.83)577 (67.80)266.31<0.001<0.001
 Yes607 (68.67)479 (54.93)359 (41.17)274 (32.20)
Obesity
 No195 (21.29)327 (36.29)434 (49.32)534 (61.95)333.79<0.001<0.001
 Yes721 (78.71)574 (63.71)446 (50.68)328 (38.05)
Compound obesity
 No363 (40.47)500 (56.56)632 (70.46)698 (79.41)326.59<0.001<0.001
 Yes534 (59.53)384 (43.44)265 (29.54)181 (20.59)
Hypertension
 No793 (87.33)811 (90.41)803 (89.72)807 (92.44)13.1230.0040.001
 Yes115 (12.67)86 (9.59)92 (10.28)66 (7.56)
Dyslipidaemia
 No219 (23.88)368 (40.48)414 (46.15)401 (46.20)127.09<0.001<0.001
 Yes698 (76.12)541 (59.52)483 (53.85)467 (53.80)
  • P values were for the χ2 analyses across the groups. Significant p-values (p < 0.05) were in bold.

  • High BMI level was defined as BMI≥24.0 kg/m2.

  • High WC level was defined as a waistline ≥80 cm for females or ≥85 cm for males.

  • Obesity was defined as high BMI level or high WC level.

  • Compound obesity was defined as the combination of high BMI level and high WC level.

  • Hypertension was defined as SBP≥140 mm Hg or DBP≥90 mm Hg.

  • Dyslipidaemia was defined as the presence of one or more of the following criteria: TC≥5.20 mmol/L or TG≥1.70 mmol/L or HDL-C<1.00 mmol/L or LDL-C≥3.4 mmol/L.

  • *Linear-by-linear association.

  • BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; T2DM, type 2 diabetes mellitus; TG, triglycerides; WC, waist circumference.